Jan 19, 2022
This week’s View highlights the use of ICD therapy in ischemic vs. non-ischemic cardiomyopathy; what are the (FDG)-positron emission tomography (PET) and MRI findings, and abnormalities in patients with COVID-19; and a meta-analysis examining oral anticoagulation in AFib.
Jan 12, 2022
This week’s View discusses the one-year outcomes of blinded physiological assessment of residual ischemia after successful PCI (DEFINE PCI); delineating whether coronary artery spasm is epicardial, microvascular, or both; and the comparison of different strategies for identifying cardiac testing in patients with...
Dec 22, 2021
This week’s View looks at differences in results of the REDUCE-IT (Reduction of Cardiovascular Events With Icosapent Ethyl-Intervention Trial) and STRENGTH (Long-Term Outcomes Study to Assess Statin Residual Risk With Epanova in High Cardiovascular Risk Patients With Hypertriglyceridemia) trials and if they can...
Dec 15, 2021
This week’s View examines the clinical course and short-term outcomes of suspected myocarditis following COVID-19 vaccination in patients <21 years of age; the effect of empagliflozin in patients with heart failure across the spectrum of LVEF; and the safety and immunogenicity profiles of different COVID-19...
Dec 9, 2021
This week’s View examines whether high-grade premature ventricular contractions (PVCs) during stress testing predict mortality in asymptomatic individuals; trends in transcatheter mitral valve therapies in the United States; and key perspectives on the newly released ACC/AHA/SCAI Coronary...